Global Internet Of Medical Things (IOMT) For Drug Delivery Market
Medical Equipment

IoMT-Based Drug Delivery Market Anticipated to Reach $10.09 Billion by 2030

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Is The Internet Of Medical Things (IOMT) For Drug Delivery Market’s Market Value Anticipated To Evolve From 2026 To 2030?

The internet of medical things (iomt) for drug delivery market size has shown substantial growth in recent years. This market is set to expand from $6.57 billion in 2025 to $7.14 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.8%. Throughout the historical period, this expansion can be linked to factors like the increasing occurrence of chronic diseases, the prompt uptake of smart infusion and monitoring equipment, the development of home healthcare provisions, a heightened emphasis on medication adherence, and the enhancement of digital health infrastructure.

The internet of medical things (IoMT) for drug delivery market is projected to experience substantial expansion over the upcoming years. This market is predicted to reach $10.09 billion by 2030, driven by a compound annual growth rate (CAGR) of 9.0%. Factors contributing to this anticipated growth include the broadening of personalized medicine applications, increased investments in connected healthcare platforms, a surging need for remote patient management, greater incorporation of AI-powered dosing algorithms, and enhanced regulatory backing for digital therapeutics. Key trends expected during the forecast period encompass a rise in the uptake of connected drug delivery devices, more widespread utilization of real-time patient monitoring platforms, increasing integration of wearable and implantable delivery systems, the development of personalized dosage management solutions, and a heightened emphasis on remote therapy management.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33187&type=smp

What Market Drivers Are Helping Shape The Internet Of Medical Things (IOMT) For Drug Delivery Market Expansion?

The increasing prevalence of telehealth and remote care solutions is anticipated to drive the expansion of the Internet of Medical Things (IoMT) for drug delivery market in the future. These services involve providing healthcare via digital platforms, allowing individuals to get medical advice, oversight, and therapy from their residences, eliminating the need for physical visits. The growth in telehealth and remote care can be attributed to a surge in patient desire for accessible, immediate healthcare, enabling them to consult physicians, track their well-being, and manage therapies from home, thereby reducing hospital trips. The Internet of Medical Things (IoMT) for drug delivery facilitates telehealth and remote care by offering real-time tracking of how well patients follow their medication, precise and automated drug delivery, and smooth information exchange with healthcare professionals. This empowers doctors to remotely oversee treatment evolution, modify dosages, and provide customized care without needing physical appointments. For example, in April 2023, FAIR Health Inc., a US-based non-profit organization, reported that national telehealth utilization saw an increase of 7.3%, climbing from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. Consequently, the expanding embrace of telemedicine platforms is fueling the expansion of the Internet of Medical Things (IoMT) for drug delivery market.

How Is The Internet Of Medical Things (IOMT) For Drug Delivery Market Distributed Across Key Segments?

The internet of medical things (iomt) for drug delivery market covered in this report is segmented –

1) By Type: Wearable Drug Delivery Devices; Smart Inhalers; Injectable Drug Delivery Systems; Implantable Drug Delivery Devices; Remote Drug Monitoring

2) By Connectivity: Bluetooth And Low Energy Connectivity; Wi Fi Connectivity; Cellular Connectivity; Near Field Communication; Cloud And Edge Based Connectivity

3) By Application: Chronic Disease Management; Acute Care Drug Delivery; Home Based Drug Administration; Hospital And Clinical Drug Delivery; Personalized And Precision Medicine

4) By End User: Hospitals And Clinics; Home Care Settings; Pharmaceutical And Biotechnology Companies; Research And Development Organizations; Contract Research And Clinical Trial Centers

Subsegments:

1) By Wearable Drug Delivery Devices: On Body Infusion Pumps; Patch Based Drug Delivery Systems; Wearable Insulin Delivery Devices; Wearable Pain Management Devices

2) By Smart Inhalers: Connected Metered Dose Inhalers; Connected Dry Powder Inhalers; Medication Adherence Monitoring Inhalers; Dose Tracking Inhaler Systems

3) By Injectable Drug Delivery Systems: Connected Auto Injectors; Smart Pen Injectors; Pre Filled Smart Syringes; Electronic Injection Monitoring Systems

4) By Implantable Drug Delivery Devices: Implantable Infusion Pumps; Controlled Release Implant Systems; Programmable Drug Delivery Implants; Long Term Therapeutic Implants

5) By Remote Drug Monitoring: Medication Adherence Monitoring Systems; Real Time Dosage Tracking Platforms; Remote Therapy Management Systems; Patient Compliance Monitoring Solutions

Which Trends Are Shaping The Internet Of Medical Things (IOMT) For Drug Delivery Market Landscape?

Prominent companies within the internet of medical things (IoMT) for drug delivery market are dedicating efforts to developing inventive solutions, such as connected smart drug-delivery devices equipped with real-time monitoring. These advancements are designed to enable personalized dosing, enhance treatment adherence, and elevate patient outcomes. Connected smart drug-delivery devices with real-time monitoring are defined as medical instruments that autonomously track medication dispensation and patient data, sharing this information wirelessly with applications or healthcare systems to optimize dosing, improve adherence, and facilitate timely clinical decisions. For instance, in November 2024, the Ireland-based healthcare technology company, Medtronic plc, launched its Smart MDI system, which incorporates the InPen app with Simplera CGM. This system integrates a smart insulin pen with a disposable, all-in-one continuous glucose monitor (CGM) to offer real-time, personalized insulin dosing insights, including recommendations for identifying and correcting missed or inaccurate mealtime doses. It consistently monitors glucose levels, records insulin administration, and analyzes patient data through a mobile application to mitigate hyperglycemia risk and support improved glycemic control. Unlike conventional insulin pens, this solution provides automated data capture, intelligent alerts, and comprehensive clinical decision support, thereby significantly reducing dosing uncertainties and contributing to better patient outcomes.

Which Companies Form The Competitive Landscape Of The Internet Of Medical Things (IOMT) For Drug Delivery Market?

Major companies operating in the internet of medical things (iomt) for drug delivery market are Siemens AG, F. Hoffmann-La Roche AG, IBM Corporation, Bayer AG, Oracle Corporation, Abbott Laboratories, Honeywell Life Care Solutions Inc., Medtronic plc, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Becton Dickinson and Company, Cognizant Technology Solutions Corporation, Biogen Inc., Omron Healthcare Co. Ltd., Dexcom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Senseonics Inc., AdhereTech Inc., Adherium Limited

Access The Complete Internet Of Medical Things (IOMT) For Drug Delivery Market Report:

https://www.thebusinessresearchcompany.com/report/internet-of-medical-things-iomt-for-drug-delivery-market-report

Which Region Holds The Largest Share In The Internet Of Medical Things (IOMT) For Drug Delivery Market?

North America was the largest region in the internet of medical things (IOMT) for drug delivery market in 2025. The regions covered in the internet of medical things (iomt) for drug delivery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Internet Of Medical Things (IOMT) For Drug Delivery Market Report for Deeper Competitive Insights

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model